Innovative thinking for complex problems

Back

SOMAXA PARTNERS WITH 4D BIOMEDICAL

5th January 2010, Somaxa Ltd, a company specialising in medical data solutions for healthcare and pharmaceutical clients, today announced a strategic partnership with 4D Biomedical Ltd, a specialist consultancy with expertise in translational medicine.

The Somaxa / 4D partnership brings together the skills of each consultancy organisation to help address challenges facing the life science industry, with a particular interest in the generation of value from electronic medical data for patients, healthcare professionals and pharmaceutical research and development (R&D).

“We are delighted to be able to partner with 4D Biomedical. 4D is renowned for the creation of translational medicine hubs that harness academic excellence, medical expertise and industry application. We are excited to be able to contribute the expertise of Somaxa to support 4D’s future work in what is proving to be an exciting field.” said Dr Julie Barnes, founding Director of Somaxa.

George Freeman, 4D’s Consulting Director, said “Somaxa are unique in having a real depth of understanding of the life science technology that can be applied to healthcare data as well as an understanding of its potential application for R&D. This will be of tremendous value to our clients.”

-Ends-

About Somaxa

With over 30 years combined experience in pharmaceutical research and development, Somaxa works with medical data and technology partners to deliver solutions to business problems for healthcare and pharmaceutical research and development.

About 4D Biomedical

4D Biomedical is a specialist biomedical consultancy business specialising in translational experimental healthcare, headquartered in Cambridge UK. The 4D Biomedical team have worked on a number of leading UK Academic Health Science Institutes developing new models for accelerating biomedical innovations in healthcare and new partnerships with Industry, having advised on the ground breaking $50m biomarker collaboration between the Scottish NHS, 4 lead Universities and Wyeth Pharmaceuticals launched in April 2006.

Back